Bladder cancer: Pelvic lymphadenectomy revisited
β Scribed by Harry W. Herr
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 396 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
The value of pelvic lymphadenectomy in patients undergoing cystectomy for bladder cancer is controversial. While perhaps 1-2 percent of all patients may be cured after excision of positive nodes, the overall contribution of this procedure to survival is minimal. Pelvic lymphadenectomy is however becoming more valuable for staging and therapy in combination with more effective systemic chemotherapy and its role in the overall management of patients with invasive bladder cancer is presently being redefined.
π SIMILAR VOLUMES
## Abstract ## Objective To assess whether pelvic lymphadenectomy at surgical staging for endometrial carcinoma is an independent risk factor for the occurrence of postoperative complications. ## Methods Women with uterine cancer who underwent radical abdominal hysterectomy type I or II of Piver
Between 1985 and 1990, five cases of radiation-induced bladder cancer were treated at our center. The first primary neoplasm was uterine cervical cancer in three patients, uterine endometrial cancer in one patient, and Hodgkin's disease in one patient. Additional treatment for the primary neoplasm i
Background and Objectives: Pelvic lymphocysts have been reported mainly following pelvic lymphadenectomy for cervical cancer. We attempted to assess whether retroperitoneal partial ''no-closure'' reduces the incidence of lymphocyst formation following retroperitoneal lymphadenectomy. Methods: Sixty-
Regional lymph node cells from some patients with locally advanced bladder carcinoma were found to inhibit the reactivity of normal and autologous peripheral blood lymphocytes in mixed leukocyte culture. The data suggest that suppressor cells are generated in draining lymph nodes of these patients b